Oxford BioMedica plc (LON:OXB) insider Lorenzo Tallarigo bought 29,685 shares of Oxford BioMedica plc stock in a transaction dated Friday, September 22nd. The shares were bought at an average cost of GBX 9 ($0.12) per share, with a total value of £2,671.65 ($3,602.06).

Shares of Oxford BioMedica plc (LON:OXB) traded up 2.24% on Friday, reaching GBX 9.11. 886,161 shares of the company’s stock traded hands. The stock’s market cap is GBX 281.34 million. Oxford BioMedica plc has a 52-week low of GBX 2.98 and a 52-week high of GBX 11.25. The firm’s 50-day moving average is GBX 8.85 and its 200-day moving average is GBX 6.66.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/22/lorenzo-tallarigo-buys-29685-shares-of-oxford-biomedica-plc-oxb-stock.html.

Several research firms recently commented on OXB. N+1 Singer raised their price objective on shares of Oxford BioMedica plc from GBX 8.70 ($0.12) to GBX 10.20 ($0.14) and gave the stock a “hold” rating in a report on Thursday, August 31st. Jefferies Group LLC reaffirmed a “buy” rating and issued a GBX 13 ($0.18) price objective on shares of Oxford BioMedica plc in a report on Thursday, August 31st. Shore Capital reaffirmed a “not rated” rating on shares of Oxford BioMedica plc in a report on Thursday, July 13th. Finally, Peel Hunt began coverage on shares of Oxford BioMedica plc in a report on Tuesday. They issued a “buy” rating and a GBX 13 ($0.18) price objective for the company.

About Oxford BioMedica plc

Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company’s segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners.

Insider Buying and Selling by Quarter for Oxford BioMedica plc (LON:OXB)

Receive News & Ratings for Oxford BioMedica plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica plc and related companies with MarketBeat.com's FREE daily email newsletter.